tubercidin has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Chen, J; Fan, L; Liu, P; Qiu, S; Xu, Y; Yu, L; Zhang, M; Zhang, X | 1 |
| Chiang, CH; Perng, WC; Wu, CP; Yan, HC; Yu, CP | 1 |
2 other study(ies) available for tubercidin and Reperfusion Injury
| Article | Year |
|---|---|
EZH2 inhibitor DZNep modulates microglial activation and protects against ischaemic brain injury after experimental stroke.
Topics: Animals; Apoptosis; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Reperfusion Injury; STAT3 Transcription Factor; Tubercidin; Up-Regulation | 2019 |
Use of anti-(tumour necrosis factor-alpha) antibody or 3-deaza-adenosine as additives to promote protection by University of Wisconsin solution in ischaemia/reperfusion injury.
Topics: Adenosine; Allopurinol; Animals; Antibodies, Monoclonal; Glutathione; Hemodynamics; Insulin; Lung; Lung Transplantation; Male; Organ Culture Techniques; Organ Preservation; Organ Preservation Solutions; Organ Size; Raffinose; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tubercidin; Tumor Necrosis Factor-alpha | 2000 |